Can extra support ease the burden of AML? new study says yes.

NCT ID NCT02975869

Completed Symptom relief Sponsor: Massachusetts General Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether adding a palliative care team to standard cancer care improves quality of life for people with acute myeloid leukemia (AML). 160 hospitalized patients with high-risk AML were randomly assigned to receive either usual oncology care or care that included a palliative care specialist. The goal was to see if this combined approach could reduce symptoms, improve mood, and help with coping during treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute myeloid leukemia leukemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE MYELOID LEUKEMIA

Contacts and locations

Show contact details

Locations

Duke University

Durham, North Carolina, 27710, United States
Massachusetts general Hospital

Boston, Massachusetts, 02114, United States
Ohio State University

Columbus, Ohio, 43210, United States
University of Pennsylvania

Philadelphia, Pennsylvania, 16802, United States